Almitas Capital »

Cortexyme shares owned by Almitas Capital

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Almitas Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $807k 495k 1.63
2024-09-30 $297k 383k 0.78

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin SHS (FBTC)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Blackrock Mun Target Term Tr Com Shs Ben In (BTT)
Blackrock Mun Target Term Tr Com Shs Ben In (BTT)
Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals (AMLX)
Fidelity Ethereum SHS (FETH)
Fidelity Ethereum SHS (FETH)
Asa Gold And Precious Mtls L SHS (ASA)
Asa Gold And Precious Mtls L SHS (ASA)
Design Therapeutics (DSGN)
Design Therapeutics (DSGN)
Cannae Holdings (CNNE)
Cannae Holdings (CNNE)
Lyell Immunopharma Com New (LYEL)

View all positions for Almitas Capital

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Millennium Management
Ieq Capital
ADAR1 Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
BlackRock
HighTower Advisors
Union Square Park Capital Management
Marshall Wace
State Street Corporation
Alphabet
Shay Capital

View all funds holding Cortexyme